A股異動 | 道氏技術(300409.SZ)漲超13% 料上半年淨利同比增801.95%-1001.2%
格隆匯7月12日丨道氏技術(300409.SZ)股價延續近期強勢,現報29.6元創2018年5月份以來新高,漲幅13.19%,最新總市值166.1億,換手率14%。公司12日公吿稱,預計今年上半年歸屬於上市公司股東的淨利潤2.28億元-2.78億元,同比增長801.95%-1001.20%。主要由於,新能源行業的高景氣發展,鈷鹽、三元前驅體產品和石墨烯/碳納米管導電劑產品訂單充足,產品結構優化,毛利率同比大幅提升,銷售產品量價齊升,驅動了公司業績增長。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.